264 related articles for article (PubMed ID: 14740605)
1. UK Commission concludes international patent laws hinder access to medicines in developing countries.
Elliott R
Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):59. PubMed ID: 14740605
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
3. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
4. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
5. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
6. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure.
Jung Y; Kwon S
Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858
[TBL] [Abstract][Full Text] [Related]
7. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA.
Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557
[TBL] [Abstract][Full Text] [Related]
8. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
9. Patents and the obligation to protect health: examining the significance of human rights considerations in the protection of pharmaceutical patents.
Owoeye OA
J Law Med; 2014 Jun; 21(4):900-19. PubMed ID: 25087369
[TBL] [Abstract][Full Text] [Related]
10. Implications of bilateral free trade agreements on access to medicines.
Correa CM
Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551
[TBL] [Abstract][Full Text] [Related]
11. Essential drugs in the new international economic environment.
Velásquez G; Boulet P
Bull World Health Organ; 1999; 77(3):288-92. PubMed ID: 10212525
[TBL] [Abstract][Full Text] [Related]
12. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
Sampat BN; Amin T
J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
[TBL] [Abstract][Full Text] [Related]
13. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
14. The dilemma of intellectual property rights for pharmaceuticals: the tension between ensuring access of the poor to medicines and committing to international agreements.
Cohen JC; Illingworth P
Dev World Bioeth; 2003 May; 3(1):27-48. PubMed ID: 14577451
[TBL] [Abstract][Full Text] [Related]
15. The Health Impact Fund: incentives for improving access to medicines.
Banerjee A; Hollis A; Pogge T
Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894
[No Abstract] [Full Text] [Related]
16. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
Luo J; Kesselheim AS
AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
[TBL] [Abstract][Full Text] [Related]
17. Lift patent barriers to increase access to medicines, says commission.
Zarocostas J
BMJ; 2006 Apr; 332(7545):814. PubMed ID: 16601039
[No Abstract] [Full Text] [Related]
18. Benchmarking progress in tackling the challenges of intellectual property, and access to medicines in developing countries.
Musungu SF
Bull World Health Organ; 2006 May; 84(5):366-70. PubMed ID: 16710545
[TBL] [Abstract][Full Text] [Related]
19. Patent immorality?
Bloche MG; Jungman ER
Am J Bioeth; 2002; 2(3):48-9. PubMed ID: 12230859
[No Abstract] [Full Text] [Related]
20. Delivering drugs to the poor: will the TRIPS Amendment help?
Dutfield G
Am J Law Med; 2008; 34(2-3):107-24. PubMed ID: 18697688
[No Abstract] [Full Text] [Related]
[Next] [New Search]